Cholangitis sclerosing and Acute kidney failure

Summary:

Acute kidney failure is found among people with Cholangitis sclerosing, especially for people who are male, 10-19 old.

The study analyzes which people have Acute kidney failure with Cholangitis sclerosing. It is created by eHealthMe based on reports of 11 people who have Cholangitis sclerosing from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Cholangitis sclerosing?

Cholangitis sclerosing (infection and obstruction of bile duct) is found to be associated with 190 drugs and 283 conditions by eHealthMe. Check the latest studies of Cholangitis sclerosing.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,835 drugs and 4,492 conditions by eHealthMe. Check the latest studies of Acute kidney failure.



On Jul, 16, 2026

11 people who have Cholangitis Sclerosing and Acute Kidney Failure are studied.

Would you have Acute kidney failure when you have Cholangitis sclerosing?

Gender of people who have Cholangitis Sclerosing and experienced Acute Kidney Failure *:

  • female: 40 %
  • male: 60 %

Age of people who have Cholangitis Sclerosing and experienced Acute Kidney Failure *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 40 %
  • 20-29: 20 %
  • 30-39: 20 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 20 %

Common co-existing conditions for these people *:

  1. White Blood Cell Count Increased: 4 people, 36.36%
  2. Pleural Effusion (water on the lungs): 4 people, 36.36%
  3. Nausea And Vomiting: 4 people, 36.36%
  4. Nausea (feeling of having an urge to vomit): 4 people, 36.36%
  5. Infection: 4 people, 36.36%
  6. Headache (pain in head): 4 people, 36.36%
  7. C-Reactive Protein Increased: 4 people, 36.36%
  8. Immunodeficiency: 3 people, 27.27%
  9. Inflammatory Bowel Disease: 2 people, 18.18%
  10. Dehydration (dryness resulting from the removal of water): 2 people, 18.18%

Common drugs taken by these people *:

  1. Ursodeoxycholic Acid: 4 people, 36.36%
  2. Sodium Chloride 0.9%: 4 people, 36.36%
  3. Ondansetron: 4 people, 36.36%
  4. Colecalciferol: 4 people, 36.36%
  5. Codeine: 4 people, 36.36%
  6. Rocaltrol: 1 person, 9.09%
  7. Prednisone: 1 person, 9.09%
  8. Pantoprazole Sodium: 1 person, 9.09%
  9. Entocort Ec: 1 person, 9.09%
  10. Azathioprine: 1 person, 9.09%

Common symptoms for these people *:

  1. Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 4 people, 36.36%
  2. Oedema Peripheral (superficial swelling): 4 people, 36.36%
  3. Blood Creatinine Increased: 4 people, 36.36%
  4. Rashes (redness): 3 people, 27.27%
  5. Drug Hypersensitivity: 3 people, 27.27%
  6. Epstein-Barr Virus Infection: 3 people, 27.27%
  7. Diabetes: 3 people, 27.27%
  8. Anaemia (lack of blood): 3 people, 27.27%
  9. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 27.27%
  10. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Acute kidney failure:

All the conditions that are associated with Acute kidney failure:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Acute kidney failure and Cholangitis sclerosing, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: